Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SERA PROGNOSTICS, INC.

(SERA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
10.41(c) 10.6(c) 10.42(c) 10.22(c) 10.0332 Last
20 484 22 982 45 375 13 067 1 262 Volume
-5.36% +1.83% -1.70% -1.92% -1.83% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 0,19 M - -
Net income 2021 -31,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,84x
Yield 2021 -
Sales 2022 6,70 M - -
Net income 2022 -38,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -8,24x
Yield 2022 -
Capitalization 314 M 314 M -
Capi. / Sales 2021 1 625x
Capi. / Sales 2022 46,8x
Nbr of Employees 73
Free-Float 85,1%
More Financials
Company
Sera Prognostics, Inc. is a womenÔÇÖs health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers... 
Sector
Business Support Services
Calendar
-
More about the company
All news about SERA PROGNOSTICS, INC.
12/01Sera Prognostics Says Study Confirms Performance of Its Biomarkers to Address Preterm B..
MT
12/01Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/S..
PR
11/30SERA PROGNOSTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
11/30Sera Prognostics, Inc. Appoints Sandra A. J. Lawrence to Board of Directors
CI
11/09SERA PROGNOSTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K
PU
11/09SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
AQ
11/09Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $23,000
MT
11/09Sera Prognostics Reports Third Quarter 2021 Financial Results
PR
11/09Sera Prognostics, Inc. Announces Unaudited Earnings Results for the third Quarter and n..
CI
11/08SERA PROGNOSTICS, INC. : Change in Directors or Principal Officers, Financial Statements a..
AQ
11/08Sera Prognostics Announces The Appointment Of Zhenya Lindgardt To The Board
PR
11/08Sera Prognostics Inc. Announces the Appointment of Zhenya Lindgardt to the Board
CI
11/03Sera Prognostics Announces Publication of the Clinical Validation of PreTRM« Threshold ..
PR
11/03Sera Prognostics Announces Publication of the Clinical Validation of PreTRM? Threshold ..
CI
11/02Sera Prognostics, Inc. Announces Collaboration to Help Underserved Communities Make Inf..
CI
More news
News in other languages on SERA PROGNOSTICS, INC.
12/01Sera Prognostics affirme que l'étude confirme la performance de ses biomarqueurs dans l..
11/09Earnings Flash (SERA) SERA PROGNOSTICS affiche un chiffre d'affaires de 23 000 $ pour l..
08/30La perte de Sera Prognostics au deuxième trimestre se creuse par rapport à l'année préc..
08/30Earnings Flash (SERA) SERA PROGNOSTICS annonce un chiffre d'affaires de 20 000 $ pour l..
07/15Les actions de Sera Prognostics dégringolent lors de leur entrée au Nasdaq
More news
Analyst Recommendations on SERA PROGNOSTICS, INC.
More recommendations
Chart SERA PROGNOSTICS, INC.
Duration : Period :
Sera Prognostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 10,22 $
Average target price 18,50 $
Spread / Average Target 81,0%
EPS Revisions
Managers and Directors
Gregory C. Critchfield Chairman, President & Chief Executive Officer
Jay M. Moyes Chief Financial Officer
John J. Boniface Chief Scientific Officer
Thomas J. Garite Vice President-Clinical Sciences
Robert Gardner Harrison Chief Information Officer